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Summary statement 29 
Activation of JNK by endoplasmic reticulum stress kinetically precedes activation of 30 
XBP1 by IRE1α. JNK-dependent induction of several inhibitors of apoptosis inhibits 31 
apoptosis early in the endoplasmic reticulum stress response. 32 
Abstract 33 
Accumulation of unfolded proteins in the endoplasmic reticulum (ER) activates the 34 
unfolded protein response (UPR). In mammalian cells, UPR signals generated by 35 
several ER membrane resident proteins, including the bifunctional protein kinase 36 
endoribonuclease IRE1α, control cell survival and the decision to execute apoptosis. 37 
Processing of XBP1 mRNA by the RNase domain of IRE1α promotes survival of ER 38 
stress, while activation of the mitogen-activated protein kinase JNK by IRE1α late in 39 
the ER stress response promotes apoptosis. Here we show that activation of JNK in 40 
the ER stress response precedes activation of XBP1. This activation of JNK is 41 
dependent on IRE1α and TRAF2 and coincides with JNK-dependent induction of 42 
expression of several antiapoptotic genes, including cIAP1, cIAP2, XIAP, and BIRC6. 43 
ER-stressed jnk1-/- jnk2-/- mouse embryonic fibroblasts (MEFs) display more 44 
pronounced mitochondrial permeability transition and increased caspase 3/7 activity 45 
compared to wild type MEFs. Caspase 3/7 activity is also elevated in ER-stressed 46 
ciap1-/- ciap2-/-, and xiap-/- MEFs. These observations suggest that JNK-dependent 47 
transcriptional induction of several inhibitors of apoptosis contributes to inhibiting 48 
apoptosis early in the ER stress response. 49 
Introduction 50 
Perturbation of protein folding homeostasis in the endoplasmic reticulum (ER) 51 
activates several signal transduction pathways collectively called the unfolded protein 52 
response (UPR) (Ron and Walter, 2007; Walter and Ron, 2011). In mammalian cells, 53 
the UPR is initiated by several ER membrane resident proteins, including the protein 54 
kinase-endoribonuclease (RNase) IRE1α (Tirasophon et al., 1998; Wang et al., 1998), 55 
the protein kinase PERK (Harding et al., 1999; Shi et al., 1999; Shi et al., 1998), and 56 
several type II transmembrane transcription factors such as ATF6α (Yoshida et al., 57 
2000) and CREB-H (Zhang et al., 2006). All of these signalling molecules activate 58 
prosurvival, but also proapoptotic responses to ER stress. 59 
These opposing signalling outputs are exemplified by IRE1α. The RNase activity 60 
of IRE1α initiates non-spliceosomal splicing of the mRNA for the transcription factor 61 
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XBP1 (Calfon et al., 2002; Lee et al., 2002; Shen et al., 2001; Yoshida et al., 2001), 62 
which in turn induces transcription of genes encoding ER-resident molecular 63 
chaperones (Lee et al., 2003), components of the ER-associated protein degradation 64 
machinery (Oda et al., 2006; Yoshida et al., 2003), and several phospholipid 65 
biosynthetic genes (Lee et al., 2003; Lee et al., 2008) to promote cell survival. The 66 
IRE1α RNase activity also initiates the decay of several mRNAs encoding proteins 67 
targeted to the ER (Gaddam et al., 2013; Han et al., 2009; Hollien et al., 2009; Hollien 68 
and Weissman, 2006), which decreases the protein folding load of the stressed ER. 69 
Degradation of DR5 mRNA by IRE1α contributes to establishment of a time window 70 
for adaptation to ER stress (Lu et al., 2014). On the other hand, IRE1α promotes 71 
apoptosis via both its RNase and protein kinase domains. Cleavage of several 72 
miRNAs, including miRNA-17, -34a, -96, and -125b, by the RNase domain of IRE1α 73 
stabilises and promotes translation of TXNIP and caspase-2 mRNAs (Lerner et al., 74 
2012; Oslowski et al., 2012; Upton et al., 2012). TXNIP promotes apoptosis through 75 
activation of caspase-1 and secretion of interleukin 1β (Lerner et al., 2012). The role 76 
of caspase-2 in ER stress-induced apoptosis has recently been questioned (Lu et al., 77 
2014; Sandow et al., 2014). The kinase domain of IRE1α activates the mitogen-78 
activated protein (MAP) kinase JNK through formation of a complex with the E3 79 
ubiquitin ligase TRAF2 and the MAP kinase kinase kinase (MAPKKK) ASK1 80 
(Nishitoh et al., 2002; Urano et al., 2000). Sequestration of TRAF2 by IRE1α may 81 
also contribute to activation of caspase-12 in murine cells (Yoneda et al., 2001). 82 
Pharmacologic (Chen et al., 2008; Huang et al., 2014; Jung et al., 2014; Jung et al., 83 
2012; Smith and Deshmukh, 2007; Teodoro et al., 2012; Wang et al., 2009; Zhang et 84 
al., 2001) and genetic (Arshad et al., 2013; Kang et al., 2012) studies have provided 85 
evidence that activation of JNK 12 h or later after induction of ER stress is 86 
proapoptotic. 87 
Much less is known about the role of JNK at earlier time points in the ER stress 88 
response. In tumour necrosis factor (TNF)-α-treated cells two phases of JNK 89 
activation can be distinguished (Lamb et al., 2003; Roulston et al., 1998), an early and 90 
transient antiapoptotic and a later phase, that coincides with activation of caspases 91 
(Roulston et al., 1998). In the early phase JNK induces expression of JunD and the 92 
antiapoptotic ubiquitin ligase cIAP2/BIRC3 (Lamb et al., 2003). Furthermore, 93 
phosphorylation of Bad at T201 and subsequent inhibition of interaction of Bad with 94 
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Bcl-xL underlies the antiapoptotic role of JNK in interleukin (IL)-3-dependent 95 
hematopoietic cells (Yu et al., 2004), while JNK mediates IL-2-dependent survival of 96 
T cells through phosphorylation of MCL1 (Hirata et al., 2013). This functional 97 
dichotomy of transient and persistent JNK signalling prompted us to investigate 98 
whether an initial phase of JNK activation exists in the ER stress response and to 99 
characterise the functional significance of such an initial phase of JNK activation in 100 
ER-stressed cells. 101 
Results 102 
ER stress activates JNK before XBP1 splicing reaches maximal levels 103 
To investigate how early JNK is activated in the ER stress response we characterised 104 
JNK activation over an 8 h time course by monitoring phosphorylation of JNK in its 105 
T-loop on T183 and Y185 by Western blotting with antibodies against phosphorylated 106 
and total JNK. In mouse embryonic fibroblasts (MEFs), phosphorylation of JNK in its 107 
T-loop increased as early as 10 min after addition of 1 μM thapsigargin (Fig. 1A,C) or 108 
10 μg/ml tunicamycin (Fig. 1D,F). JNK phosphorylation returned to near basal levels 109 
8 h after addition of thapsigargin or tunicamycin to cells. The ability of these two 110 
mechanistically different ER stressors to elicit rapid phosphorylation of JNK, which 111 
over several hours declines to near basal levels, suggests that this initial phase of JNK 112 
activation is caused by ER stress invoked by these two chemicals and not a response 113 
to secondary effects of these compounds. To compare the kinetics of JNK activation 114 
to the kinetics of the XBP1 splicing reaction and phosphorylation of the PERK 115 
substrate eIF2α we monitored XBP1 splicing by using reverse transcriptase (RT)-PCR 116 
and phosphorylation of eIF2α on S51 by Western blotting. Spliced XBP1 mRNA 117 
differs from unspliced XBP1 mRNA by lacking a 26 nt intron. Hence, the presence of 118 
a shorter RT-PCR product on agarose gels is indicative of activation of the IRE1α 119 
RNase activity and processing of XBP1 mRNA. In thapsigargin-treated MEFs ~45% 120 
of XBP1 mRNA were spliced 20 min after addition of thapsigargin (Fig. 1B,C). XBP1 121 
splicing reached maximal levels only after several hours of thapsigargin treatment, 122 
suggesting that activation of JNK precedes maximal activation of XBP1. 123 
Phosphorylation of eIF2α was observed within 10 min after induction of ER stress 124 
with 1 μM thapsigargin, which indicates that both eIF2α and JNK are phosphorylated 125 
before significant levels of XBP1 mRNA are spliced (Fig. 1B,C). When ER stress was 126 
induced with 10 μg/ml tunicamycin, phosphorylation of JNK and eIF2α also preceded 127 
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splicing of XBP1 (Fig. 1D-F). Furthermore, XBP1 splicing reached maximal levels 128 
only after JNK phosphorylation returned to near basal levels in tunicamycin-treated 129 
MEFs. In both thapsigargin- and tunicamycin-treated MEFs phosphorylation of eIF2α 130 
declined towards the end of the time course, which is consistent with the transient 131 
nature of the translational arrest mediated by eIF2α S51 phosphorylation (Kojima et 132 
al., 2003; Novoa et al., 2003). 133 
To investigate whether a similar kinetic relationship between phosphorylation of 134 
JNK and eIF2α and XBP1 splicing exists in other cell types, we repeated these 135 
experiments with Hep G2 hepatoma cells, 3T3-F442A adipocytes, and C2C12 136 
myotubes. In Hep G2 cells, JNK phosphorylation increased 30 min after addition of 1 137 
μM thapsigargin to the cells and then declined to near resting levels after ~120 min of 138 
thapsigargin exposure (Fig. S1A,C). By contrast, 30 min after addition of thapsigargin 139 
only ~7% of XBP1 mRNA were spliced, and after another 15 min XBP1 splicing was 140 
approximately half maximal (Fig. S1B,C). XBP1 splicing reached maximal levels 141 
only after 6 h of thapsigargin treatment. In 3T3-F442A adipocytes phosphorylation of 142 
JNK reached a maximum as early as 10 min after application of 1 μM thapsigargin, 143 
then returned to basal levels before increasing again towards the end of the time 144 
course (Fig. S1D,F). XBP1 splicing, however, was not detectable until 45 min after 145 
addition of thapsigargin, required 4 h to reach maximal levels, and remained at this 146 
level for at least another 4 h (Fig. S1E,F). Thus, activation of JNK also precedes 147 
activation of XBP1 in Hep G2 cells and 3T3-F442A adipocytes and also returns to 148 
near basal levels of JNK activity after several hours of ER stress. We made the same 149 
observations in C2C12 myotubes. In these cells an increase in JNK phosphorylation 150 
was detected as early as 10 min after induction of ER stress with 1 μM thapsigargin 151 
(Fig. S1G,H,J), while the earliest time point at which an increase in XBP1 splicing 152 
was detected was 20 min (Fig. S1I,J). At the same time, activation of JNK diminished 153 
over time in C2C12 myotubes, while the level of XBP1 splicing remained at maximal 154 
levels (Fig. S1H-J). In all three cell lines, phosphorylation of both eIF2α and JNK 155 
preceded splicing of XBP1 (Fig. S1). We conclude that  activation of JNK preceding 156 
induction of XBP1 splicing and leading to an initial phase of JNK activity are 157 
phenomena that can be observed in several ER-stressed murine and human cell types. 158 
The initial phase of JNK activation in ER-stressed cells requires IRE1α and TRAF2 159 
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Several different stresses activate JNK (Kyriakis et al., 1994). To examine if the rapid 160 
JNK activation seen upon thapsigargin or tunicamycin treatment is in response to ER 161 
stress and thus mediated via IRE1α and TRAF2, we characterised whether this rapid 162 
JNK activation is IRE1α- and TRAF2-dependent. Activation of JNK in the first ~60 163 
min after induction of ER stress with 1 μM thapsigargin was decreased in ire1α-/- and 164 
traf2-/- MEFs compared to WT MEFs and did no longer reach statistical significance 165 
(Figs 1, 2). In both ire1α-/- and traf2-/- MEFs JNK activation was delayed and reached 166 
maximal levels only towards the end of the 8 h time course (Fig. 2). This delayed 167 
activation of JNK may be explained by stresses other than and possibly secondary to 168 
ER stress, for example oxidative stress (Mauro et al., 2006). Before the onset of the 169 
delayed phosphorylation of JNK in ire1α-/- and traf2-/- MEFs, phosphorylation of JNK 170 
was higher in WT MEFs than in the ire1α-/- or traf2-/- MEFs (Fig. 2G), suggesting that 171 
the early JNK activation in ER-stressed cells requires both IRE1α and TRAF2. 172 
To establish if the initial phase of JNK activation is IRE1α- and TRAF2-173 
dependent in cells other than MEFs we characterised whether small interfering (si)-174 
RNA-mediated knockdown of IRE1α or TRAF2 reduces JNK activation by ER stress. 175 
Two IRE1α siRNAs (#2 and #3, Table S1) reduced IRE1α mRNA levels to ~40% of 176 
control eGFP siRNA transfected cells 72 h post-transfection (Fig. S2A) and decreased 177 
activation of JNK to 60 ± 17% and 30 ± 9% of eGFP siRNA-transfected cells, 178 
respectively (Fig. S2B,C). Likewise, two siRNAs against human or murine TRAF2 179 
blunted the ER stress-dependent JNK activation in Hep G2 cells, 3T3-F442A 180 
fibroblasts, and C2C12 myoblasts (Figs S2D-F, S3). Furthermore, a dominant negative 181 
mutant of TRAF2, TRAF2Δ1-86 (Hsu et al., 1996; Reinhard et al., 1997), which lacks 182 
the RING domain (Fig. S4A) inhibited TNF-α-induced JNK activation (Fig. S4B) and 183 
blunted the initial phase of JNK activation upon induction of ER stress with 1 μM 184 
thapsigargin in 3T3-F442A preadipocytes (Fig. S4C,D) and C2C12 myoblasts (Fig. 185 
S4E,F). Taken together, these data demonstrate that the initial phase of JNK 186 
activation upon induction of ER stress is mediated by both IRE1α and TRAF2. 187 
The initial phase of JNK activation in ER-stressed cells inhibits cell death via 188 
induction of inhibitors of apoptosis (IAPs) 189 
An initial phase of JNK activation by stresses other than ER stress is viewed as being 190 
antiapoptotic (Chen et al., 1996a; Lee et al., 1997; Nishina et al., 1997; Raingeaud et 191 
al., 1995; Sluss et al., 1994; Traverse et al., 1994). To characterise whether JNK 192 
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activation early in the ER stress response is also antiapoptotic, we studied whether 193 
mitochondrial permeability transition (MPT) is more pronounced in JNK-deficient 194 
MEFs than WT MEFs, because MPT is often observed in apoptotic cells (Bradham et 195 
al., 1998; Fulda et al., 1998; Narita et al., 1998; Scorrano et al., 1999). After exposure 196 
of cells to 1 μM thapsigargin or 10 μg/ml tunicamycin for up to 4 h MPT was 197 
revealed by staining cells with the fluorescent dye 5,5’,6,6’-tetrachloro-1,1’,3,3’-198 
tetraethylbenzimidazolylcarbocyanine iodide (JC-1) (Reers et al., 1991; Smiley et al., 199 
1991) (Fig. 3A). MPT inhibits accumulation of JC-1 in mitochondria and blue-shifts 200 
its fluorescence emission from a punctuate orange to a green fluorescence (Reers et 201 
al., 1991). After induction of ER stress with 1 μM thapsigargin for 45 min or 4 h MPT 202 
was observed in a greater percentage of jnk1-/- jnk2-/- MEFs than WT MEFs (Fig. 203 
3A,B). Similar results were obtained when ER stress was induced with 10 μg/ml 204 
tunicamycin for 4 h (Fig. 3A,C). To provide further evidence for increased apoptotic 205 
cell death in JNK-deficient cells we measured caspase 3/7-like protease activities 206 
early in the ER stress response (Fig. 3D,E). Two ER stressors, thapsigargin and 207 
tunicamycin, elicited a more pronounced increase of caspase 3/7-like protease 208 
activities in jnk1-/- jnk2-/- MEFs than in WT MEFs 4 h after induction of ER stress 209 
(Fig. 3D,E). These data suggest that JNK signalling early in the ER stress response 210 
inhibits apoptosis. 211 
In the early antiapoptotic response to TNF-α JNK is required for expression of the 212 
mRNA for the antiapoptotic ubiquitin ligase cIAP2/BIRC3 (Lamb et al., 2003). This 213 
motivated us to compare the expression of mRNAs for antiapoptotic genes including 214 
cIAP1, cIAP2, XIAP, and BIRC6 at the onset of activation of JNK with 1 μM 215 
thapsigargin in WT and jnk1-/- jnk2-/- MEFs. Expression of the mRNAs for cIAP1, 216 
cIAP2, XIAP, and BIRC6 increased in WT cells in the first 45 min of ER stress. By 217 
contrast, cIAP1, cIAP2, and BIRC6 mRNA levels decreased in jnk1-/- jnk2-/- cells (Fig. 218 
4). The increase in XIAP mRNA was more pronounced in WT than in jnk1-/- jnk2-/- 219 
MEFs, suggesting that JNK positively regulates expression of XIAP mRNA (Fig. 4C). 220 
To establish whether mammalian inhibitors of apoptosis (IAPs) delay the onset of 221 
apoptosis in the early ER stress response we compared caspase 3/7-like protease 222 
activity in WT, ciap1-/- ciap2-/-, and xiap-/- MEFs. Both ciap1-/- ciap2-/- and xiap-/- 223 
MEFs displayed 4.4 ± 1.2 fold higher caspase 3/7-like protease activities than WT 224 
MEFs under unstressed conditions (Fig. 5A), which is consistent with increased 225 
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susceptibility of these cells and cells treated with IAP antagonists to undergo 226 
apoptosis (Conte et al., 2006; Geserick et al., 2009; Schimmer et al., 2004; Vince et 227 
al., 2007; Yang and Du, 2004). ER stress induced for 4 h with thapsigargin or 228 
tunicamycin resulted in a greater increase in caspase 3/7-like protease activities in 229 
ciap1-/- ciap2-/- and xiap-/- MEFs than in WT MEFs (Fig. 5B,C). Taken together, the 230 
decreased transcriptional induction of several IAPs in jnk1-/- jnk2-/- MEFs, increased 231 
MPT and increased caspase 3/7-like protease activities in JNK-deficient MEFs, 232 
ciap1-/- ciap2-/-, and xiap-/- MEFs suggest that JNK-dependent transcriptional 233 
induction of several IAPs inhibits apoptosis early in the ER stress response. 234 
Discussion 235 
We show that JNK is activated early in the mammalian UPR and that this immediate 236 
JNK activation is antiapoptotic. Activation of JNK early in the UPR by two 237 
mechanistically distinct ER stressors, thapsigargin and tunicamycin (Figs 1, S1), and 238 
its dependence on IRE1α and TRAF2 (Figs 2, S2-S4) provides evidence that the early 239 
JNK activation is in response to ER stress. Greater activation of caspase 3/7-like 240 
protease activities and a more rapid MPT were observed in ER-stressed JNK-deficient 241 
MEFs than in WT MEFs (Fig. 3). These data support the view that early JNK 242 
activation protects ER-stressed cells from executing apoptosis prematurely and are 243 
consistent with the observation that traf2-/- MEFs are more susceptible to ER stress 244 
than WT MEFs (Mauro et al., 2006). Early JNK activation coincides with induction of 245 
several antiapoptotic genes (Figs 1, 4). Maximal expression of these mRNAs was 246 
JNK-dependent (Fig. 4). MEFs lacking several IAPs, such as ciap1-/- ciap2-/- and 247 
xiap-/- MEFs, displayed greater caspase 3/7-like protease activities than WT MEFs 248 
during short periods of ER stress (Fig. 5). These observations support the view that 249 
IAPs, whose transcriptional induction is JNK-dependent in the early ER stress 250 
response, protect cells against apoptosis early in the ER stress response. 251 
Mostly pharmacologic data support that activation of JNK late in the ER stress 252 
response promotes cell death (Arshad et al., 2013; Chen et al., 2008; Huang et al., 253 
2014; Jung et al., 2014; Jung et al., 2012; Kang et al., 2012; Smith and Deshmukh, 254 
2007; Tan et al., 2006; Teodoro et al., 2012; Wang et al., 2009; Zhang et al., 2001). 255 
Our work suggests that two functionally distinct phases of JNK signalling exist in the 256 
ER stress response - an early prosurvival phase and a late phase that promotes cell 257 
death. Biphasic JNK signalling with opposing effects on cell viability exists also in 258 
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other stress responses. Transient activation of JNK in response to several other 259 
stresses is antiapoptotic (Chen et al., 1996a; Lee et al., 1997; Nishina et al., 1997; 260 
Raingeaud et al., 1995; Sluss et al., 1994; Traverse et al., 1994), while persistent JNK 261 
activation causes cell death (Chen et al., 1996a; Chen et al., 1996b; Guo et al., 1998; 262 
Sanchez-Perez et al., 1998). These opposing functional attributes of transient and 263 
persistent JNK activation have also been causally established by using JNK-deficient 264 
MEFs reconstituted with 1-tert-butyl-3-naphthalen-1-ylmethyl-1H-pyrazolo[3,4-265 
d]pyrimidin-4-ylemine (1NM-PP1)-sensitised alleles of JNK1 and JNK2 (Ventura et 266 
al., 2006). Hence, the antiapoptotic function of the initial phase of JNK activation in 267 
the ER stress response is another example for the paradigm that the duration of JNK 268 
activation controls cell fate. Identification of cIAP1, XIAP, and BIRC6 as genes whose 269 
expression required JNK in the early response to ER stress (Fig. 4) has allowed us to 270 
extend the repertoire of antiapoptotic JNK targets. These, and possibly other genes, 271 
may also contribute to how JNK inhibits cell death in other stress responses. 272 
The existence of an initial antiapoptotic phase of JNK signalling in the ER stress 273 
response raises at least two questions: 1) What are the molecular mechanisms that 274 
define this initial phase as antiapoptotic? 2) Which mechanisms may restrict 275 
antiapoptotic JNK signalling to the early response to ER stress? While future 276 
experiments will be necessary to answer these questions, possible explanations may 277 
be that the duration of activation affects the subcellular localisation of JNKs, that JNK 278 
signalling outputs are controlled by molecular determinants, or that the JNK 279 
signalling pathway functionally interacts with other signalling pathways, for example 280 
the NF-κB pathway. 281 
Opposing signalling outputs of extracellular signal-regulated kinases (ERKs) in 282 
PC12 cells have been explained by different subcellular localisations of ERKs 283 
(Marshall, 1995). JNK, however, does not appear to relocalise upon stimulation, 284 
either in response to transient or persistent activation (Chen et al., 1996a; Sanchez-285 
Perez et al., 1998). This is also the case for JNK activated early in the ER stress 286 
response (Fig. 6). An alternative possibility is that JNK substrates function as 287 
molecular determinants of the biological functions of transient and persistent JNK 288 
activation, respectively. This is, for example, the case for the ERK substrate c-Fos 289 
(Murphy et al., 2002). 290 
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In the ER stress response NF-κB activation is transient and displays kinetics in 291 
several cell lines that are reminiscent of the initial phase of antiapoptotic JNK 292 
signalling reported in this study (Deng et al., 2004; Jiang et al., 2003; Wu et al., 2002; 293 
Wu et al., 2004). In TNF-α signalling JNK functionally interacts with the NF-κB 294 
pathway. JNK activation in the absence of NF-κB is apoptotic (Deng et al., 2003; Guo 295 
et al., 1998; Liu et al., 2004; Tang et al., 2002) or necrotic (Ventura et al., 2004), 296 
while NF-κB transduces an antiapoptotic response to TNF-α (Devin et al., 2000; 297 
Kelliher et al., 1998). At the transcriptional level NF-κB cooperates with JunD 298 
(Rahmani et al., 2001), whose phosphorylation is decreased in jnk1-/- jnk2-/- MEFs 299 
(Ventura et al., 2003). NF-κB induces cIAP1, cIAP2, and XIAP (Stehlik et al., 1998). 300 
JunD contributes to the transcriptional induction of cIAP2 in TNF-α-stimulated cells 301 
(Lamb et al., 2003). This collaboration between NF-κB and transcription factors 302 
controlled by JNK, such as JunD, may explain the JNK-dependent induction of 303 
cIAP1, cIAP2, XIAP, and BIRC6 (Fig. 4), and potentially other antiapoptotic genes, 304 
early in the ER stress response. 305 
Transient activation of NF-κB in the ER stress response may also contribute to 306 
control of the duration of antiapoptotic JNK signalling. NF-κB inhibits JNK 307 
activation by TNF-α (De Smaele et al., 2001; Papa et al., 2004; Reuther-Madrid et al., 308 
2002; Tang et al., 2002; Tang et al., 2001) through induction of XIAP (Tang et al., 309 
2002; Tang et al., 2001) and GADD45β (De Smaele et al., 2001; Papa et al., 2004). 310 
TNF-α also induces the dual specificity phosphatase MKP1/DUSP1 (Guo et al., 311 
1998). In murine keratinocytes cis-platin induces persistent JNK activation but 312 
induces MKP1 only weakly, while transient JNK activation by trans-platin correlated 313 
with strong induction of MKP1 (Sanchez-Perez et al., 1998). shRNA-mediated knock-314 
down of MKP1 elevated JNK phosphorylation by tunicamycin in C17.2 neural stem 315 
cells, which correlated with increased caspase-3 cleavage and decreased cell viability 316 
(Li et al., 2011). These observations suggest that MKP1 is a negative regulator of 317 
JNK in ER-stressed cells. However, it remains unresolved if the effects of the MKP1 318 
knock-down on caspase-3 cleavage and cell viability are causally mediated via JNK 319 
or other MKP1 substrates, such as the p38 MAP kinases (Boutros et al., 2008). In 320 
tunicamycin-, but not DTT-treated cerebellar granule neurons S359 phosphorylation 321 
and stabilisation of MKP1 were observed, which correlated with short-term JNK 322 
activation in tunicamycin-treated cells and prolonged JNK activation in DTT-treated 323 
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cells (Li et al., 2011). While these results suggest that MKP1 may control the duration 324 
of JNK activation in ER-stressed cells, they may also be the result of different 325 
pharmacokinetics or secondary effects of the two ER stressors, especially as JNK is 326 
activated by diverse stresses (Kyriakis et al., 1994). For example, DTT chelates heavy 327 
metal ions, including Zn2+ ions, with pK values of ~10-15 (Cornell and Crivaro, 1972; 328 
Gnonlonfoun et al., 1991; Krężel et al., 2001) and thus may affect many metal-329 
dependent proteins. DTT can also alter proton gradients over membranes (Petrov et 330 
al., 1992), because of its pKa of ~9.2 (Whitesides et al., 1977), and may reduce 331 
lipoamide and through this affect pyruvate dehydrogenase and ATP generation, 332 
because its standard redox potential is more negative than the standard redox potential 333 
of lipoamide (Cleland, 1964; Massey, 1960). Hence, additional experimentation is 334 
required to characterise the role of MKP1 in the ER stress response. 335 
The duration of JNK activation may also be regulated at the level of the ER stress 336 
perceiving protein kinase IRE1α. Activation of JNK by IRE1α requires interaction of 337 
TRAF2 with IRE1α (Urano et al., 2000). This interaction has not been observed in 338 
cells expressing kinase and RNase-defective K599A-IRE1α (Urano et al., 2000). JNK 339 
activation precedes XBP1 splicing (Figs 1, S1). XBP1 splicing by mammalian IRE1α 340 
is stimulated by phosphorylation of IRE1α (Prischi et al., 2014). Hence, overall 341 
phosphorylation of IRE1α seems to be an unlikely explanation for the transiency of 342 
JNK activation. It is, however, possible that the specific pattern of phosphorylation of 343 
the ~10 phosphorylation sites in IRE1α (Itzhak et al., 2014) controls its affinity 344 
towards TRAF2 and the activation of JNK by IRE1α. 345 
In conclusion, we show that an initial phase of JNK activation produces 346 
antiapoptotic signals early in the ER stress response. Our work also identifies JNK-347 
dependent expression of several antiapoptotic genes, including cIAP1, cIAP2, and 348 
XIAP, as a mechanism through which JNK exerts its antiapoptotic functions early in 349 
the ER stress response. 350 
Materials and Methods 351 
Antibodies and reagents. Rabbit anti-phospho-S51-eIF2α (cat. no. 9721S, batches 352 
10-12), rabbit anti-JNK (cat. no. 9252, batch 15) rabbit anti-JNK2 (cat. no. 9258, 353 
batch 9), rabbit anti-phospho-JNK (cat. no. 4668, batches 9 and 11) antibodies, and 354 
human recombinant TNF-α (cat. no. 8902) were purchased from Cell Signaling 355 
Technology Inc. (Danvers, MA, USA). The mouse anti-GAPDH antibody (cat. no. 356 
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G8795, batch 092M4820V) was purchased from Sigma-Aldrich (Gillingham, UK), 357 
the rabbit anti-eIF2α antibody (cat. no. sc-11386, batch G1309) and the rabbit anti-358 
TRAF2 antibody (cat. no. sc-876, batches G1508 and J2009) from Santa Cruz 359 
Biotechnology (Santa Cruz, CA, USA), and the mouse anti-emerin antibody (cat. no. 360 
ab49499) from Abcam (Cambridge, UK). siRNAs against TRAF2, IRE1α, and eGFP 361 
were obtained from Sigma-Aldrich. siRNA sequences are listed in Table S1. 362 
Tunicamycin was purchased from Merck Chemicals (Beeston, UK) and thapsigargin 363 
from Sigma-Aldrich (Gillingham, UK). 364 
Plasmids. Plasmids were maintained in Escherichia coli XL10-Gold cells (Agilent 365 
Technologies, Stockport, UK, cat. no. 200314). Standard protocols for plasmid 366 
constructions were used. Plasmid pMT2T-TRAF2Δ1-86 was generated by amplifying 367 
a 1,327 bp fragment from pMT2T-HA-TRAF2 (Leonardi et al., 2000) with primers 368 
H8215 and H8216 (Table S2). The PCR product was cleaved with ClaI and NotI and 369 
cloned into ClaI- and NotI-digested pMT2T-HA-TRAF2 to yield pMT2T-TRAF2Δ1-370 
86. The TRAF2 region in pMT2T-TRAF2Δ1-86 was confirmed by sequencing. 371 
Cell culture. WT, ire1α-/- (Lee et al., 2002), jnk1-/- jnk2-/- (Tournier et al., 2000), 372 
traf2-/- (Yeh et al., 1997), ciap1-/- ciap2-/- (Geserick et al., 2009), and xiap-/- (Vince et 373 
al., 2008) MEFs were provided by R. J. Kaufman (Sanford Burnham Medical 374 
Research Institute, La Jolla, CA, USA), R. Davis (University of Massachusetts, 375 
Worchester, MA, USA), T. Mak (University of Toronto, Ontario Cancer Institute, 376 
Toronto, Ontario, Canada), and J. Silke (Walter+Eliza Hall Institute for Medical 377 
Research, Victoria, Australia), respectively. 3T3-F442A preadipocytes (Green and 378 
Kehinde, 1976), C2C12 myoblasts (Blau et al., 1985), and Hep G2 cells (Knowles et 379 
al., 1980) were obtained from C. Hutchison (Durham University), R. Bashir (Durham 380 
University), and A. Benham (Durham University), respectively. All cell lines were 381 
tested for mycoplasma contamination upon receipt in the laboratory with the EZ-PCR 382 
mycoplasma test kit from Geneflow (cat. no. K1-0210, Lichfield, UK). Mycoplasma 383 
testing was repeated every ~3 months with all cells in culture at that time. 384 
Contaminated cultures were discarded. 385 
All cell lines were grown at 37°C in an atmosphere of 95% (v/v) air, 5% (v/v) 386 
CO2, and 95% humidity. Hep G2 cells were grown in minimal essential medium 387 
(MEM) (Eagle, 1959) supplemented with 10% (v/v) foetal bovine serum (FBS) and 2 388 
mM L-glutamine. All other cell lines were grown in Dulbecco’s modified Eagle’s 389 
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medium (DMEM) containing 4.5 g/l D-glucose (Morton, 1970; Rutzky and Pumper, 390 
1974), 10% (v/v) FBS, and 2 mM L-glutamine. The medium for ire1α-/- and 391 
corresponding WT MEFs was supplemented with 110 mg/l pyruvate (Lee et al., 392 
2002). To differentiate C2C12 cells 60-70% confluent cultures were shifted into low 393 
mitogen medium consisting of DMEM containing 4.5 g/l D-glucose, 2% (v/v) horse 394 
serum, and 2 mM L-glutamine and incubated for another 7-8 d while replacing the 395 
low mitogen medium every 2-3 d (Bains et al., 1984). Differentiation of C2C12 cells 396 
was assessed by microscopic inspection of cultures, staining of myotubes with 397 
rhodamine-labelled phalloidin (Amato et al., 1983), and reverse transcriptase PCR for 398 
transcription of the genes encoding S-adenosyl-homocysteine hydrolase (AHCY), 399 
myosin light chain 1 (MYL1), and troponin C (TNNC1, Fig. S1G). 3T3-F442A 400 
fibroblasts were differentiated into adipocytes as described before (Mihai and 401 
Schröder, 2015). Adipocyte differentiation was assessed by analysing nile red-stained 402 
cells by flow cytometry as described before (Mihai and Schröder, 2015). ER stress 403 
was induced with 1 μM thapsigargin or 10 μg/ml tunicamycin, if not stated otherwise. 404 
Hep G2 cells were transfected with plasmids using jetPRIME (Polyplus 405 
Transfection, Illkirch, France, cat. no. 114) and with siRNAs using INTERFERin 406 
(Polyplus Transfection, cat. no. 409) transfection reagents. Plasmids and siRNAs were 407 
transfected into all other cell lines by electroporation with a Neon electroporator (Life 408 
Technologies, Paisley, UK) using a 10 μl tip. Manufacturer-optimised electroporation 409 
conditions were used for 3T3-F442A preadipocytes and C2C12 myoblasts. MEFs were 410 
electroporated with one pulse of 1200 V and a pulse width of 30 ms. 10-20 nM of 411 
each siRNA were transfected. The control siRNA was designed against the enhanced 412 
green fluorescent protein (eGFP) from Aequora victoria. Transfection efficiencies 413 
were determined by transfection of 2 μg of pmaxGFP (Lonza Cologne GmbH, 414 
Cologne, Germany) and detection of GFP-expressing cells with a Zeiss ApoTome 415 
fluorescence microscope. Transfection efficiencies were >80%. 24 h after transfection 416 
cells were analysed or time courses initiated, if not stated otherwise. 417 
RNA extraction and RT-PCRs. RNA was extracted with the EZ-RNA total RNA 418 
isolation kit (Geneflow, cat. no. K1-0120) and reverse transcribed with oligo-dT 419 
primers (Promega, Southampton, cat. no. C1101) and Superscript III reverse 420 
transcriptase (Life Technologies, cat. no. 18080044) as described previously (Cox et 421 
al., 2011). Protocols for detection of splicing of murine and human XBP1 have been 422 
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described previously (Cox et al., 2011). In brief, 2.5 μl of the cDNA synthesis 423 
reaction were amplified with 1 μM of primers H8289 and H8290 for human XBP1 424 
and primers H7961 and H7962 for murine XBP1 in a 50 μl reaction containing 1 x 425 
GoTaq reaction buffer (Promega, cat. no. M7911), 1.5 mM MgCl2, 200 μM dNTPs, 426 
and 0.05 U/ml GoTaq hot start polymerase (Promega, cat. no. M5001). The reaction 427 
was incubated for 2 min at 94°C, and then cycled for 35 cycles consisting of 428 
subsequent incubations at 94°C for 1 min, 59°C for 1 min, and 72°C for 30 s, followed 429 
by a final extension step at 72°C for 5 min. ACTB was amplified under the same 430 
conditions as described for XBP1 except that GoTaq G2 Flexi DNA polymerase 431 
(Promega, cat. no. M7801) was used. Human ACTA1 was amplified with primers 432 
H8287 and H8288 and murine ACTB with primers H7994 and H7995. Primer 433 
sequences are listed in Table S2. Band intensities were quantified using ImageJ 434 
(Collins, 2007) and the percentage of XBP1 splicing calculated by dividing the signal 435 
for spliced XBP1 mRNA by the sums of the signals for spliced and unspliced XBP1 436 
mRNAs. Quantitative PCRs (qPCRs) were run on a Rotorgene 3000 (Qiagen, 437 
Crawley, UK). Amplicons were amplified with 0.5 μl 5 U/μl GoTaq® Flexi DNA 438 
polymerase (Promega, cat. no. M8305), 2 mM MgCl2, 200 μM dNTPs, and 1 μM of 439 
each primer and detected with a 1:167,000 fold dilution of a SybrGreen stock solution 440 
(Life Technologies, cat. no. S7563) or the GoTaq qPCR Master Mix from Promega 441 
(cat. no. A6002). Primers for qPCR are listed in Table S2. qPCR using GoTaq DNA 442 
polymerase were performed as follows. After denaturation for 2 min at 95°C samples 443 
underwent 40 cycles of denaturation at 95°C for 30 s, primer annealing at 58°C for 30 444 
s, and primer extension at 72°C for 30 s. After denaturation at 95°C for 2 min qPCRs 445 
with the GoTaq qPCR Master mix were cycled 40 times at 95°C for 15 s, 60°C for 15 446 
s, and 72°C for 15 s for cIAP1, cIAP2, XIAP, and BRUCE and 40 times at 95°C for 15 447 
s, 60°C for 60 s for ACTB. Fluorescence data were acquired during the annealing step 448 
or in case of qPCR amplification of ACTB with the GoTaq qPCR Master Mix during 449 
the first 30 s at 60°C. Amplification of a single PCR product was confirmed by 450 
recording the melting curves after each PCR run. Average amplification efficiencies 451 
in the exponential phase were calculated using the comparative quantification analysis 452 
in the Rotor Gene Q software and were between 0.6 and 0.7 for all qPCRs. CT values 453 
were calculated and normalised to GAPDH, ACTA1, or ACTB mRNA levels as 454 
described by Pfaffl (Pfaffl, 2001) taking the average amplification efficiencies into 455 
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account. Results represent the average and standard error (s.e.m.) of three technical 456 
repeats. qPCR results were confirmed by at least one other biological replicate. 457 
Murine AHCY, MYL1, and TNNC qPCRs were standardised to GAPDH, murine 458 
BIRC6, cIAP1, cIAP2, TRAF2, and XIAP qPCRs to ACTB, the human IRE1α qPCR to 459 
GAPDH and the human TRAF2 qPCR to ACTA1. 460 
Cell lysis and Western blotting. Cells were washed three times with ice-cold 461 
phosphate-buffered saline (PBS, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, 27 mM KCl, 462 
137 mM NaCl, pH 7.4) and lysed in RIPA buffer [50 mM Tris-HCl, pH 8.0, 150 mM 463 
NaCl, 0.5% (w/v) sodium deoxycholate, 0.1% (v/v) Triton X-100, 0.1% (w/v) SDS] 464 
containing Roche complete protease inhibitors (Roche Applied Science, Burgess Hill, 465 
UK, cat. no. 11836153001) as described before (Cox et al., 2011). 466 
For isolation of cytosolic and nuclear fractions cells were washed two times with 467 
ice-cold PBS and gently lysed in 0.32 M sucrose, 10 mM Tris-HCl pH 8.0, 3 mM 468 
CaCl2, 2 mM Mg(OAc)2, 0.1 mM EDTA, 0.5% (v/v) NP-40, 1 mM DTT, 0.5 mM 469 
PMSF. Nuclei were collected by centrifugation for 5 min at 2,400 g, 4°C. The 470 
supernatant was used as the cytosolic fraction. The nuclear pellet was resuspended in 471 
0.32 M sucrose, 10 mM Tris HCl pH 8.0, 3 mM CaCl2, 2 mM Mg(OAc)2, 0.1 mM 472 
EDTA, 1 mM DTT, 0.5 mM PMSF by flipping the microcentrifuge tube. The nuclei 473 
were collected by centrifugation for 5 min at 2,400 g, 4°C. After aspiration of all of 474 
the wash buffer the nuclei were resuspended in 30 μl low salt buffer [20 mM HEPES 475 
(pH 7.9), 1.5 mM MgCl2, 20 mM KCl, 0.2 mM EDTA, 25% (v/v) glycerol, 0.5 mM 476 
DTT, 0.5 mM PMSF] by flipping the microcentrifuge tube. One volume of high salt 477 
buffer [20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 800 mM KCl, 0.2 mM EDTA, 25% 478 
glycerol (v/v), 1% NP-40, 0.5 mM DTT, 0.5 mM PMSF] was added drop wise while 479 
continuously mixing the contents of the microcentrifuge tube by flipping. The tubes 480 
were then incubated for 45 min at 4°C on an end-over-end rotator. The tubes were 481 
centrifuged at 14,000 g for 15 min at 4°C and the supernatant transferred into a fresh 482 
microcentrifuge tube to obtain the nuclear extract. 483 
Proteins were separated by SDS-PAGE and transferred to polyvinylidene 484 
difluoride (PVDF) membranes (Amersham HyBondTM-P, pore size 0.45 μm, GE 485 
Healthcare, Little Chalfont, UK, cat. no. RPN303F) by semi-dry electrotransfer in 0.1 486 
M Tris, 0.192 M glycine, and 5% (v/v) methanol at 2 mA/cm2 for 60-75 min. 487 
Membranes were blocked for 1 h in 5% (w/v) skimmed milk powder in TBST [20 488 
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mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% (v/v) Tween-20] or 5% bovine serum 489 
albumin (BSA) in TBST and then incubated overnight with the primary antibody at 490 
4°C and gentle agitation. Blots were washed three times with TBST and then probed 491 
with secondary antibody for 1 h at room temperature. The anti-eIF2α, anti-phospho-492 
S51-eIF2α, anti-JNK, anti-phospho-JNK, and anti-TRAF2 antibodies were used at a 493 
1:1,000 dilution in TBST + 5% (w/v) BSA. Membranes were then developed with 494 
goat anti-rabbit-IgG (H+L)-horseradish peroxidase (HRP)-conjugated secondary 495 
antibody (Cell Signaling, cat. no. 7074S, batch 24) at a 1:1,000 dilution in TBST + 496 
5% (w/v) skimmed milk powder. The mouse anti-GAPDH antibody was used at a 497 
1:30,000 dilution in TBST + 5% (w/v) skimmed milk powder and developed with 498 
goat anti-mouse IgG (H+L)-HRP-conjugated secondary antibody (Thermo Scientific, 499 
cat. no. 31432, batch OE17149612) at a 1:20,000 dilution in TBST + 5% (w/v) 500 
skimmed milk powder. For signal detection Pierce ECL Western Blotting Substrate 501 
(cat. no. 32209) or Pierce ECL 2 Western Blotting Substrate (cat. no. 32132) from 502 
Thermo Fisher Scientific (Loughborough, UK) were used. Blots were exposed to CL-503 
X PosureTM film (Thermo Fisher Scientific, Loughborough, UK, cat. no. 34091). 504 
Exposure times were adjusted on the basis of previous exposures to obtain exposures 505 
in the linear range of the film. Films were scanned on a CanoScan LiDE 600F scanner 506 
(Canon) and saved as tif files. Bands were quantified using ImageJ exactly as 507 
described under the heading “Gels Submenu” on the ImageJ web site 508 
(http://rsb.info.nih.gov/ij/docs/menus/analyze.html#plot). In case of unphosphorylated 509 
proteins intensities for the experimental antibody were divided by the intensities 510 
obtained with the antibody for the loading control in the same lane to correct for 511 
differences in loading between lanes. Intensities for phosphorylated eIF2α were 512 
divided by the intensities obtained for total eIF2α in the same lane. For 513 
phosphorylated and total JNK, the sums of the intensities at 54 kDa and 46 kDa, 514 
which both represent several JNK1 and JNK2 isoforms (Gupta et al., 1996), were 515 
used to calculate the fraction of phosphorylated JNK in a similar way as described for 516 
phospho-eIF2α. Normalisation of phospho-JNK signals to JNK2 or GAPDH gave 517 
qualitatively the same results. All loading control- or unphosphorylated protein-518 
corrected intensities obtained for one Western blot were then expressed relative to the 519 
loading control-corrected intensity of the 0 h sample in this Western blot. To reprobe 520 
blots for detection of nonphosphorylated proteins, membranes were stripped using 521 
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Restore Western Blot Stripping Buffer (Thermo Fisher Scientific, cat. no. 21059) and 522 
blocked with 5% (w/v) skimmed milk powder in TBST. 523 
Caspase 3 and 7-like activities were determined with the Caspase-Glo 3/7 kit from 524 
Promega (cat. no. G8091). Luminescence was read with a Synergy H4 Multi-Mode 525 
Microplate Reader (BioTek, Swindon, UK) and standardised to total protein 526 
concentrations determined with the DC protein assay from Bio-Rad Laboratories 527 
(Hemel Hempstead, UK, cat. no. 500-0116). 528 
Fluorescence microscopy. For confocal microscopy cells were grown in lumox 529 
dishes (Sarstedt, Leichester, UK, cat. no. 94.6077.331). After incubation with 1 μM 530 
thapsigargin cells were incubated with 2 μg/ml JC-1 (Life Technologies, cat. no. 531 
T3168) at 37°C for 20 min (Ankarcrona et al., 1995; Cossarizza et al., 1993; Reers et 532 
al., 1991; Smiley et al., 1991). The cells were washed twice with PBS before addition 533 
of fresh medium for live cell imaging on a Leica TCS SP5 II confocal microscope 534 
(Leica Microsystems, Mannheim, Germany). JC-1 fluorescence was excited at 488 535 
nm with an argon laser set at 22% of its maximum power. Green fluorescence 536 
between 515-545 nm was collected with a photomultiplier tube and orange 537 
fluorescence between 590-620 nm with a HyD 5 detector. Cells showing fluorescence 538 
emission between 515-545 nm only were counted as having undergone MPT, while 539 
cells that displayed punctuate fluorescence emission between 590-620 nm were 540 
counted as not having undergone MPT. 541 
Error and statistical calculations. Samples sizes (n) were derived from experiments 542 
with independent cell cultures. Experimental data are presented as the mean and its 543 
s.e.m. For composite parameters, errors were propagated using the law of error 544 
propagation for random, independent errors (Ku, 1966). Statistical calculations were 545 
performed in GraphPad Prism 6.07 (GraphPad Software, La Jolla, CA, USA). 546 
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Figure Legends 950 
Fig. 1. JNK activation precedes activation of XBP1 splicing in MEFs. (A) Kinetics of 951 
JNK and eIF2α phosphorylation and (B) XBP1 splicing in MEFs exposed to 1 μM 952 
thapsigargin. (C) Quantification of JNK (white circles, solid line, n = 4) and eIF2α 953 
(white squares, dotted line) phosphorylation from panel (A) and of XBP1 splicing 954 
(black circles, dashed line, n = 2) from panel (B). (D) Kinetics of JNK and eIF2α 955 
phosphorylation and (E) XBP1 splicing in MEFs exposed to 10 μg/ml tunicamycin. 956 
(F) Quantification of JNK (white circles, solid line, n = 3) and eIF2α (white squares, 957 
dotted line) phosphorylation from panel (D) and of XBP1 splicing (black circles, 958 
dashed line) from panel (E). p values for comparison of the JNK phosphorylation after 959 
addition of the drugs to the cells to JNK phosphorylation in the untreated cells were 960 
obtained from an ordinary one way analysis of variance (ANOVA) with Dunnett’s 961 
correction for multiple comparisons (Dunnett, 1955; Dunnett, 1964). * - p < 0.05, ** - 962 
p < 0.01, *** - p < 0.001, and **** - p < 0.0001. A repeat of the eIF2α Western blots 963 
gave qualitatively similar results. 964 
Fig. 2. IRE1α and TRAF2 are required for the initial phase of JNK activation in 965 
MEFs. (A) Kinetics of JNK and eIF2α phosphorylation and (B) XBP1 splicing in 966 
ire1α-/- MEFs exposed to 1 μM thapsigargin. For eIF2α phosphorylation qualitatively 967 
similar data were obtained in one repeat of the experiment. (C) Quantification of JNK 968 
(white circles, solid line, n = 3) and eIF2α (white squares, dotted line) 969 
phosphorylation from panel (A) and of XBP1 splicing (black circles, dashed line) 970 
from panel (B). (D) Kinetics of JNK and eIF2α phosphorylation and (E) XBP1 971 
splicing in traf2-/- MEFs exposed to 1 μM thapsigargin. eIF2α phosphorylation was 972 
expressed relative to the 480 min time point. (F) Quantification of JNK (white circles, 973 
solid line, n = 3) and eIF2α phosphorylation (white squares, dotted line, n = 2) from 974 
panel (D) and XBP1 splicing (black circles, dashed line) from panel (E). (G) 975 
Comparison of phosphorylation of JNK in WT, ire1α-/-, and traf2-/- MEFs before the 976 
onset of elevated JNK phosphorylation after 240 min of ER stress in ire1α-/- and 977 
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traf2-/- MEFs. The bars represent the relative JNK phosphorylation before, 10, 20, 30, 978 
45, 60, 120, and 240 min after addition of thapsigargin to the cells. p values for 979 
comparison of JNK phosphorylation in treated cells to the JNK phosphorylation in 980 
untreated cells were calculated with an ordinary one way ANOVA with Dunnett’s 981 
correction for multiple comparisons. 982 
Fig. 3. JNK inhibits cell death early in the ER stress response. (A) WT and jnk1-/- 983 
jnk2-/- MEFs were treated with 1 μM thapsigargin (Tg) or 10 μg/ml tunicamycin (Tm) 984 
for 4 h and stained with JC-1 as described in Materials and Methods. Scale bar – 10 985 
μm. (B, C) Quantification of the confocal fluorescence microscopy data shown in 986 
panel A for (B) thapsigargin- and (C) tunicamycin-treated cells. At least 600 cells 987 
were counted for each sample. (D) Combined activities of caspases 3 and 7 in WT and 988 
jnk1-/- jnk2-/- MEFs treated for 4 h with 1 or 2 μM thapsigargin (Tg) or (E) 10 μg/ml 989 
tunicamycin (Tm). The combined caspase activities are expressed relative to the 990 
untreated cells. p values were calculated with an ordinary two way ANOVA with 991 
Šidák’s correction for multiple comparisons (Šidák, 1967) (n = 3 for panels D and E). 992 
Fig. 4. JNK is required for transcriptional induction of antiapoptotic genes early in the 993 
ER stress response. (A) cIAP1 (BIRC2), (B) cIAP2 (BIRC3), (C) XIAP (BIRC4), and 994 
(D) BIRC6 (BRUCE) steady-state mRNA levels were quantified by RT-qPCR in WT 995 
and jnk1-/- jnk2-/- MEFs exposed to 1 μM thapsigargin for the indicated times. The p 996 
values for the genotype comparisons of an ordinary two way ANOVA with Šidák’s 997 
correction for multiple comparisons are shown (n = 3). 998 
Fig. 5. cIAP1, cIAP2, and XIAP protect against apoptosis early in the ER stress 999 
response. (A) Combined activities of caspases 3 and 7 in untreated WT, ciap1-/- 1000 
ciap2-/-, and xiap-/- MEFs and after exposure to (B) 2 μM thapsigargin (Tg) or (C) 10 1001 
μg/ml tunicamycin (Tm) for 4 h. p values were calculated with an ordinary two way 1002 
ANOVA with Dunnett’s (panel A) or Tukey’s (Tukey, 1949) (panels B and C) 1003 
correction for multiple comparisons (n = 3). 1004 
Fig. 6. Immediately activated JNK localizes to the cytosol during ER stress. Serum-1005 
starved Hep G2 cells were treated for 45 min with 1 μM thapsigargin or left untreated 1006 
before isolation of the cytosolic and nuclear fractions. The cytosolic (C) and nuclear 1007 
(N) fractions were analysed by Western blotting. The asterisk (*) indicates a non-1008 
specific band recognised by the anti-emerin antibody. Emerin was used as a nuclear 1009 
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marker and GAPDH as a cytoplasmic marker. The experiment was repeated once with 1010 
qualitatively similar results. 1011 
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Supplemental figure legends 1 
Fig. S1. Kinetics of JNK and eIF2α phosphorylation and of XBP1 splicing in response to 2 
acute ER stress in (A-C) Hep G2 cells, (D-F) in vitro differentiated 3T3-F442A adipocytes, 3 
and (G-J) in vitro differentiated C2C12 myotubes. (A) Western blots for phospho-S51-eIF2α 4 
(pS51-eIF2α), eIF2α, phospho-JNK (p-JNK), JNK, and GAPDH and (B) XBP1 splicing in 5 
Hep G2 cells exposed to 1 µM thapsigargin for the indicated times. (C) Quantification of the 6 
JNK (white circles, solid line, n = 3) and eIF2α phosphorylation (white squares, dotted line) 7 
from panel (A) and of XBP1 splicing (black circles, dashed line) from panel (B). (D) Western 8 
blots for pS51-eIF2α, eIF2α, p-JNK, JNK, GAPDH and (E) XBP1 splicing in 3T3-F442A 9 
cells exposed to 1 µM thapsigargin for the indicated times. (F) Quantification of JNK (white 10 
circles, solid line, n = 2) and eIF2α (white squares, dotted line) phosphorylation from panel 11 
(D) and XBP1 splicing (black circles, dashed line) from panel (E). (G) mRNA levels for the 12 
muscle differentiation markers AHCY encoding S-adenosyl-homocysteine hydrolase, MYL1 13 
encoding myosin light chain 1, and TNNC1 encoding troponin C in differentiated C2C12 cells. 14 
The fold changes in mRNA abundance relative to undifferentiated cells (day 0) are shown. 15 
(H) Western blots for pS51-eIF2α, eIF2α, p-JNK, JNK, and GAPDH and (I) XBP1 splicing 16 
in C2C12 cells exposed to 1 µM thapsigargin for the indicated times. (J) Quantification of 17 
JNK (white circles, solid line, n =2) and eIF2α (white squares, dotted line, n = 2) 18 
phosphorylation from panel (H) and of XBP1 splicing (black circles, dashed line) from panel 19 
(I). p values for comparison of the JNK phosphorylation in treated to the JNK 20 
phosphorylation in untreated cells were calculated with an ordinary one way ANOVA with 21 
Dunnett’s correction for multiple comparisons. A repeat of each eIF2α Western blot gave 22 
qualitatively similar results. 23 
Fig. S2. The initial phase of JNK activation requires IRE1α and TRAF2 in Hep G2 cells. (A) 24 
Hep G2 cells were transfected with 10 nM of the indicated siRNAs against human IRE1α. 48 25 
h and 72 h after transfection IRE1α mRNA was quantified by RT-qPCR. (B) siRNA knock-26 
down of IRE1α impairs ER stress-dependent activation of JNK in Hep G2 cells. 72 h after 27 
transfection with the indicated siRNAs Hep G2 cells were stimulated for the indicated times 28 
with 1 µM thapsigargin. Cell lysates were analysed by Western blotting. (C) Quantification 29 
of JNK phosphorylation in Hep G2 cells treated for the indicated times with 1 µM 30 
thapsigargin 72 h after transfection with the indicated siRNAs. The average and s.e.m. from 31 
two independent experiments are shown. p values for comparison of the relative JNK 32 
 2 
 
phosphorylation in cells transfected with eGFP and hIRE1α siRNAs at 2 and 4 h were 33 
calculated by using an ordinary two way ANOVA test with Tukey’s correction for multiple 34 
comparisons. (D) siRNA knock-down of human TRAF2 in Hep G2 cells. Relative TRAF2 35 
mRNA abundance (to ACTA1) was measured by RT-qPCR 24 or 48 h after transfection of 36 
Hep G2 cells with the indicated siRNAs. (E) Knock-down of TRAF2 expression in Hep G2 37 
cells interferes with ER stress-induced JNK phosphorylation. Hep G2 cells were treated with 38 
1 µM thapsigargin for the times indicated before protein extraction for Western blotting with 39 
antibodies against p-JNK, JNK2, TRAF2, and GAPDH. (F) Quantification of the JNK 40 
phosphorylation signals in the Western blots of panel (E). 41 
Fig. S3. The initial phase of JNK activation is TRAF2-dependent in 3T3-F442A 42 
preadipocytes and in C2C12 myoblasts. (A, B) TRAF2 mRNA levels measured by real-time 43 
PCR in (A) 3T3-F442A preadipocytes and (B) C2C12 myoblasts after transfection with the 44 
indicated siRNAs. (C) TRAF2 protein levels relative to GAPDH in 3T3-F442A 45 
preadipocytes transfected with the indicated siRNAs against eGFP or murine TRAF2. Cells 46 
were treated with 20 ng/ml TNF-α for 20 min where indicated. (D) JNK phosphorylation and 47 
(E) XBP1 splicing in 3T3-F442A preadipocytes transfected with a siRNA against eGFP. (F) 48 
Quantification of the JNK phosphorylation (white circles, solid line) from panel (D) and 49 
XBP1 splicing (black circles, dashed line) from panel (E). (G) JNK phosphorylation and (H) 50 
XBP1 splicing in 3T3-F442A preadipocytes transfected with murine TRAF2 siRNA #2. (I) 51 
Quantification of the JNK phosphorylation (white circles, solid line, n = 3) from panel (G) 52 
and XBP1 splicing (black circles, dashed line, n = 2) from panel (H). (J) JNK 53 
phosphorylation and (K) XBP1 splicing in C2C12 myoblasts transfected with control siRNA 54 
against eGFP. (L) Quantification of the JNK phosphorylation (white circles, solid line, n = 2) 55 
from panel (J) and XBP1 splicing (black circles, dashed line, n = 2) from panel (K). (M) JNK 56 
phosphorylation and (N) XBP1 splicing in C2C12 myoblasts transfected with murine TRAF2 57 
siRNA #2. (O) Quantification of the JNK phosphorylation (white circles, solid line, n = 3) 58 
from panel (M) and XBP1 splicing (black circles, dashed line) from panel (N). p values for 59 
comparison of the JNK phosphorylation in treated to the JNK phosphorylation in untreated 60 
cells were calculated with an ordinary one way ANOVA with Dunnett’s correction for 61 
multiple comparisons. 62 
Fig. S4. Dominant negative TRAF2 blocks initial JNK activation by ER stress in 3T3-F442A 63 
preadipocytes (C-D) and C2C12 myotubes (E-F). (A) Domain structures of WT and dominant-64 
negative TRAF2 (TRAF2∆1-86). (B) Western blots for phospho-JNK, JNK2, and TRAF2 in 65 
 3 
 
cell lysates prepared from WT and traf2-/- MEFs transiently transfected with 8 µg pMT2T-66 
TRAF2∆1-86 and stimulated with 50 ng/ml TNF-α for 20 min where indicated. (C) JNK 67 
phosphorylation in 3T3-F442A preadipocytes transfected with pMT2T-TRAF2∆1-86 to 68 
express dominant-negative TRAF2∆1-86. (D) Quantification of the JNK phosphorylation 69 
signals in the Western blots of panel (C). (E) JNK phosphorylation in C2C12 myoblasts 70 
transfected with pMT2T-TRAF2∆1-86 to express dominant-negative TRAF2∆1-86. (F) 71 
Quantification of the JNK phosphorylation signals. 72 
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Table S1. siRNAs. 1 
Species Gene # Sequence 
Homo sapiens IRE1α 1 GCGUAAAUUCAGGACCUAUdTdT 
H. sapiens IRE1α 2 GAUAGUCUCUGCCCAUCAAdTdT 
H. sapiens IRE1α 3 CAUUGCACGUGAAUUGAUAdTdT 
H. sapiens TRAF2 1 CACUCAGAGUGGGAGCACAdTdT 
H. sapiens TRAF2 2 GUCAAGACUUGUGGCAAGUdTdT 
H. sapiens TRAF2 3 GCCUUCAGGCCCGACGUGAdTdT 
Mus musculus TRAF2 1 GAAUUCCUAUGUGCGGGAUdTdT 
M. musculus TRAF2 2 GUUAGAGCAUGCAGCAAAUdTdT 
M. musculus TRAF2 3 CTATGAAGGCCTGTATGAAdTdT 
Aequora victora eGFP  GCAAGCUGACCCUGAAGUUCAU 
 2 
 1 
 
Table S2. Oligodeoxynucleotides. Restriction sites are underlined. The start codon for 1 
TRAF2∆1-86 is shown in bold. 2 
Name Purpose Sequence 
Oligodeoxynucleotides for H. sapiens genes 
H8197 TRAF2 RT-qPCR for siRNA #3, 
reverse 
AATGGCCTTGATGAAGATGG 
H8215 TRAF2∆1-86 construction, 
forward primer 
TGCATCGATATGAGCAGTTCGGCCTTCCCA 
H8216 TRAF2∆1-86 construction, reverse 
primer 
CGAGCGGCCGCCACTGTGCTGGATATCTGC 
H8280 TRAF2 RT-qPCR for siRNA #1, 
forward 
CTTAGCCAAGGGCTGTGGT 
H8281 TRAF2 RT-qPCR for siRNA #1, 
reverse 
AGGAATGCTCCCTTCTCTCC 
H8282 TRAF2 RT-qPCR for siRNA #2, 
forward 
GTCCGCCTTGGTGAAAAG 
H8283 TRAF2 RT-qPCR for siRNA #2, 
reverse 
TCTCACCCTCTACCGTCTCG 
H8284 TRAF2 RT-qPCR for siRNA #3, 
forward 
ACACCAGCAGGTACGGCTAC 
H8285 GAPDH RT-qPCR, forward TCACCAGGGCTGCTTTTAAC 
H8286 GAPDH RT-qPCR, reverse GGCAGAGATGATGACCCTTT 
H8287 ACTA1 RT-qPCR, forward CTGAGCGTGGCTACTCCTTC 
H8288 ACTA1 RT-qPCR, reverse GGCATACAGGTCCTTCCTGA 
H8289 XBP1 PCR, forward GAGTTAAGACAGCGCTTGGG 
H8290 XBP1 PCR, reverse ACTGGGTCCAAGTTGTCCAG 
H8993 IRE1α RT-qPCR, forward TGGGACAGCTAGGCTGAGAT 
H8994 IRE1α RT-qPCR, reverse TGGGCACATCTGTGATCAAT 
Oligodeoxynucleotides for M. musculus genes 
H7961 XBP1 PCR, forward GATCCTGACGAGGTTCCAGA 
H7962 XBP1 PCR, reverse ACAGGGTCCAACTTGTCCAG 
H7994 ACTB PCR, forward AGCCATGTACGTAGCCATCC 
H7995 ACTB PCR, reverse CTCTCAGCTGTGGTGGTGAA 
 2 
 
H8237 TRAF2 RT-qPCR for siRNA #1, 
forward 
GAACTCATCTGTCTCTCTTCTTCG 
H8238 TRAF2 RT-qPCR for siRNA #1, 
reverse 
AGCAGGGGTGGCTAGAGTCC 
H8239 TRAF2 RT-qPCR for siRNA #2, 
forward 
CTGCAGAGCACCCTGTAGC 
H8240 TRAF2 RT-qPCR for siRNA #2, 
reverse 
CCTGCAGGTTCTCAGTCTCC 
H8269 TRAF2 RT-qPCR for siRNA #3, 
forward 
ACTGCTCCTTCTGCCTGACC 
H8270 TRAF2 RT-qPCR for siRNA #3, 
reverse 
TTCTTTCAAGGTCCCCTTCC 
H8271 GAPDH RT-qPCR, forward TCGTCCCGTAGACAAAATGG 
H8272 GAPDH RT-qPCR, reverse CTCCTGGAAGATGGTGATGG 
H8322 MYL1 3f RT-qPCR, forward TGCTGACCAGATTGCCGACTTCA 
H8323 MYL1 3f RT-qPCR, reverse CCCGGAGGACGTCTCCCACC 
H8326 AHCY RT-qPCR, forward GGTGCTGAGGTGCGGTGGTC 
H8327 AHCY RT-qPCR, reverse GGGTCCGTCCTTGAAGTGCAGC 
H8328 TNNC1 RT-qPCR, forward GCACCAAGGAGCTGGGCAAGG 
H8329 TNNC1 RT-qPCR, reverse TGTGCCACTGCCATCCTCGT 
H9054 cIAP1 (BIRC2) RT-qPCR, 
forward 
TAGTGTTCCTGTTCAGCCCG 
H9055 cIAP1 (BIRC2) RT-qPCR, reverse TCCCAACATCTCAAGCCACC 
H9056 cIAP2 (BIRC3) RT-qPCR, 
forward 
ACGATTTAAAGGTATCGCGCC 
H9057 cIAP2 (BIRC3) RT-qPCR, reverse CTGATACCGCAGCCCACTTC 
H9076 XIAP (BIRC4) RT-qPCR, forward ACGGAGGATGAGTCAAGTCAAA 
H9077 XIAP (BIRC4) RT-qPCR, reverse AAGTGACCAGATGTCCACAAGG 
H9080 BRUCE (BIRC6) RT-qPCR, 
forward 
CCAGTGTGAGGAGTGGATTGC 
H9081 BRUCE (BIRC6) RT-qPCR, 
reverse 
CCTCAATGTCCGGATCTAAGCC 
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